RE:RE:RE:RE:RE:What really changed?Weird how much the contrast in opinion of customers is compared to how investors see this company. Talk to the medical marijuana community about THC Biomed and they think it's cool and many of them are buying clones from them as well as happy with their experience with them. I've posted many examples of happy customers, which if there were few it would be harder to find.
Yet compare that to investor's opinion and it's completely opposite. Good financials and fully licensed, none of this seems to matter. All that matters is IR it seems and it's sad because I've been burned by companies that are great at hyping themselves up, great communication with investors, but then fall flat because of weak financials or end up screwing over customers. I thought I learned a lesson from that and always do extensive DD on a company, but this time all my DD didn't help me at all. Yes I know there was a communication problem before, but with the news of the Capital Commitment and their financials release, I felt it would be a turn around soon. Especially how undervalued it was compared to others in this sector.
Still likely to be a turn around though and good job to whoever buys this at these levels.
DiligentSon wrote: All of you guys are going to sit here and make excuses all the way into the low 50s or high 40s....and then wonder why and make excuses when it gets there. The fact of the matter is that this stock was lagging and dipping long before the CFO sell off started. The market doesn't like THC for some reason, I can't explain why, but these are minds much more cognizant than the minds on these boards who have far more insight.